VCIM
KZIA

Velan Capital Investment Management’s Kazia Therapeutics KZIA Stock Holding History

Velan Capital Investment Management’s Portfolio KZIA Stock Details KZIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.01M Sell
135,315
-164,685
-55% -$1.15M 0.63% 25
2025
Q4 		$2.07M Buy
+300,000
New +$2.56M 1.2% 23

Other funds holding KZIA

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $6.71B AUM 23.99% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Velan Capital Investment Management's KZIA Position: Q1 2026 in Review

Velan Capital Investment Management reduced its Kazia Therapeutics (KZIA) stake by 55% in Q1 2026, selling an estimated $1.15M and leaving 135,315 shares worth $1.01M. The position accounts for 0.63% of the portfolio, ranked #25.

Velan Capital Investment Management first reported a position in KZIA in Q4 2025 and has held it in 2 quarters since. The position peaked at $2.07M in Q4 2025. 23 funds tracked by Wall St. Rank hold KZIA as of Q1 2026.

  • Velan Capital Investment Management held 135,315 shares of Kazia Therapeutics worth $1.01M as of Q1 2026.
  • Velan Capital Investment Management sold 164,685 Kazia Therapeutics shares in Q1 2026, an estimated $1.15M.
  • Kazia Therapeutics made up 0.63% of Velan Capital Investment Management's portfolio in Q1 2026, its #25 holding.
  • Velan Capital Investment Management first reported a position in Kazia Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • Velan Capital Investment Management's Kazia Therapeutics position peaked at $2.07M in Q4 2025.
  • 23 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q1 2026.

Based on Velan Capital Investment Management's 13F filing for Q1 2026, filed 15 May 2026.